Quality Measures Quality Measures for the Care of Adult Patients with Restless Legs Syndrome

Journal of Clinical Sleep Medicine, Vol. 11, No. 3, 2015 The American Academy of Sleep Medicine (AASM) commissioned several Workgroups to develop quality measures for the care of patients with common sleep disorders, including adults with restless legs syndrome (RLS). Using the AASM process for quality measure development, the RLS Workgroup developed three target outcomes for RLS management, including improving the accuracy of diagnosis, reducing symptom severity, and minimizing treatment complications. Seven processes were developed to support these outcomes. To achieve the outcome of improving accuracy of diagnosis, the use of accepted diagnostic criteria and assessment of iron stores are recommended. To realize the outcome of decreasing symptom severity, routine assessment of severity and provision of evidence-based treatment are recommended. To support the outcome of minimizing treatment complications, counseling about potential side effects and assessing for augmentation and impulse control disorders, when indicated, are recommended. Further research is needed to validate optimal practice processes to achieve best outcomes in adult patients with RLS. Citation: Trotti LM, Goldstein CA, Harrod CG, Koo BB, Sharon D, Zak R, Chervin RD. Quality measures for the care of adult patients with restless legs syndrome. J Clin Sleep Med 2015;11(3):293–310. pii: jc-00027-15 http://dx.doi.org/10.5664/jcsm.4550

[1]  Kathryn A. Lee,et al.  Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactation. , 2015, Sleep medicine reviews.

[2]  R. Chervin,et al.  Measurement of quality to improve care in sleep medicine. , 2015, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[3]  J. Kassubek,et al.  What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications. , 2014, Sleep medicine reviews.

[4]  W. Ondo.  Common comorbidities and differential diagnosis of restless legs syndrome. , 2014, The Journal of clinical psychiatry.

[5]  J. Winkelmann,et al.  Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension , 2013, The Lancet Neurology.

[6]  Y. Dauvilliers,et al.  Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome. , 2013, Sleep.

[7]  W. Ondo,et al.  Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome. , 2013, Mayo Clinic proceedings.

[8]  Yuichi Inoue,et al.  The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group. , 2013, Sleep medicine.

[9]  Michael H. Silber.  Sleep-Related Movement Disorders , 2013, Continuum.

[10]  T. Wilt,et al.  Treatment for Restless Legs Syndrome , 2012 .

[11]  P. Jennum,et al.  European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society , 2012, European journal of neurology.

[12]  A. Walters,et al.  Restless legs syndrome--theoretical roles of inflammatory and immune mechanisms. , 2012, Sleep medicine reviews.

[13]  M. Ohayon,et al.  Epidemiology of restless legs syndrome: a synthesis of the literature. , 2012, Sleep medicine reviews.

[14]  Sabin R. Bista,et al.  The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. , 2012, Sleep.

[15]  A. Çurgunlu,et al.  Prevalence and characteristics of restless legs syndrome (RLS) in the elderly and the relation of serum ferritin levels with disease severity: hospital-based study from Istanbul, Turkey. , 2012, Archives of gerontology and geriatrics.

[16]  L. Trotti,et al.  Iron for restless legs syndrome. , 2012, The Cochrane database of systematic reviews.

[17]  S. Ratcliffe,et al.  The Relationship With Iron and Health Outcomes in Persons With Restless Legs Syndrome , 2011, Clinical nursing research.

[18]  D. Riemann,et al.  Dopamine agonists for restless legs syndrome. , 2011, The Cochrane database of systematic reviews.

[19]  R. Davenport.  Poor effect of guideline-based treatment of restless legs syndrome in clinical practice , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[20]  W. Oertel,et al.  Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch , 2010, BMC neurology.

[21]  J. S. Valbuza,et al.  The pharmacological treatment for uremic restless legs syndrome: Evidence‐based review , 2010, Movement disorders : official journal of the Movement Disorder Society.

[22]  W. Poewe,et al.  The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels. , 2009, Sleep medicine.

[23]  F. Torti,et al.  Ferritin for the clinician. , 2009, Blood reviews.

[24]  V. Voon,et al.  Medication-related impulse control and repetitive behaviors in Parkinson's disease , 2007, Current opinion in neurology.

[25]  A. Walters,et al.  Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. , 2007, Sleep medicine.

[26]  H. Butzkueven,et al.  Dopamine agonist‐induced pathological gambling in restless legs syndrome due to multiple sclerosis , 2007, Movement disorders : official journal of the Movement Disorder Society.

[27]  Terry Young,et al.  Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. , 2006, Sleep medicine.

[28]  Jennifer L. Kirwin,et al.  Role of pharmacist counseling in preventing adverse drug events after hospitalization. , 2006, Archives of internal medicine.

[29]  Richard P Allen,et al.  Restless legs syndrome prevalence and impact: REST general population study. , 2005, Archives of internal medicine.

[30]  R. Allen,et al.  Correlation between rating scales and sleep laboratory measurements in restless legs syndrome. , 2004, Sleep medicine.

[31]  Richard P Allen,et al.  Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. , 2004, Sleep medicine.

[32]  M. Atkinson,et al.  Health and Quality of Life Outcomes , 2004 .

[33]  R. Allen,et al.  Iron and the restless legs syndrome. , 1998, Sleep.

[34]  P. Lespérance,et al.  Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteria , 1997, Movement disorders : official journal of the Movement Disorder Society.

[35]  S. O’Keeffe,et al.  Restless legs syndrome in the elderly. , 1993, Postgraduate medical journal.

[36]  W. Poewe,et al.  Assessing treatment outcome in RLS trials and clinical care: CGI-I, PGI, or VAS? , 2013, Sleep medicine.

[37]  D. Rye,et al.  Restless legs syndrome and periodic leg movements of sleep. , 2012, Neurologic clinics.

[38]  M. Silber,et al.  Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. , 2010, Sleep.

[39]  C. Lyketsos,et al.  Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. , 2008, The Journal of neuropsychiatry and clinical neurosciences.

[40]  A. Walters,et al.  Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics , 2007, Movement disorders : official journal of the Movement Disorder Society.

[41]  W. Hening,et al.  Clinical significance of RLS , 2007, Movement disorders : official journal of the Movement Disorder Society.

[42]  W. Oertel,et al.  Clinical trials in restless legs syndrome—Recommendations of the European RLS Study Group (EURLSSG) , 2007, Movement disorders : official journal of the Movement Disorder Society.

[43]  D. Mannino,et al.  Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. , 2006, Chest.

[44]  M. Silber,et al.  Multiple blood donations associated with iron deficiency in patients with restless legs syndrome. , 2003, Mayo Clinic proceedings.

[45]  Richard P Allen,et al.  Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. , 2003, Sleep medicine.